• Je něco špatně v tomto záznamu ?

In vitro activity of carvacrol in combination with meropenem against carbapenem-resistant Klebsiella pneumoniae

EO. Köse

. 2022 ; 67 (1) : 143-156. [pub] 20211102

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22005994

Carbapenem resistance observed in Klebsiella pneumoniae strains limits treatment options. Therefore, use of antibiotics combined with bioactive compounds may be an important strategy to control K. pneumoniae. The purpose of this study was to evaluate the activity of combination of carvacrol and meropenem on carbapenem-resistant K. pneumoniae (CRKP) strains. The presence of blaOXA-48 carbapenemase in all 25 CRKP strains was identified using the PCR technique. The combination of carvacrol and meropenem was tested for antimicrobial activity on CRKP strains. The minimum inhibitory concentrations of carvacrol and meropenem were detected within a range of 32-128 μg/mL using the broth microdilution method. Synergy between carvacrol and meropenem was observed on 8 of the 25 CRKP strains by checkerboard assay (FICI = 0.5) and confirmed by time-kill assay. According to the live-dead test results, the viability percentage of the cells exposed to synergistic combination was 35.47% at the end of 24 h. The membrane damage caused by the synergistic combination was spectrophotometrically measured (A = 0.21) and further confirmed by SEM analysis. According to the MTT assay, both carvacrol and meropenem did not show any statistically significant cytotoxic effect on Vero cells (p > 0.05). In conclusion, the results suggest that carvacrol and meropenem can act synergistically to inhibit the growth of CRKP.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22005994
003      
CZ-PrNML
005      
20240416150931.0
007      
ta
008      
220207s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-021-00908-7 $2 doi
035    __
$a (PubMed)34729712
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Köse, Elif Odabaş $u Medical Laboratory Program, Vocational School of Health Services, Akdeniz University, Antalya, Turkey. elifkose@akdeniz.edu.tr $1 https://orcid.org/000000023943571X
245    10
$a In vitro activity of carvacrol in combination with meropenem against carbapenem-resistant Klebsiella pneumoniae / $c EO. Köse
520    9_
$a Carbapenem resistance observed in Klebsiella pneumoniae strains limits treatment options. Therefore, use of antibiotics combined with bioactive compounds may be an important strategy to control K. pneumoniae. The purpose of this study was to evaluate the activity of combination of carvacrol and meropenem on carbapenem-resistant K. pneumoniae (CRKP) strains. The presence of blaOXA-48 carbapenemase in all 25 CRKP strains was identified using the PCR technique. The combination of carvacrol and meropenem was tested for antimicrobial activity on CRKP strains. The minimum inhibitory concentrations of carvacrol and meropenem were detected within a range of 32-128 μg/mL using the broth microdilution method. Synergy between carvacrol and meropenem was observed on 8 of the 25 CRKP strains by checkerboard assay (FICI = 0.5) and confirmed by time-kill assay. According to the live-dead test results, the viability percentage of the cells exposed to synergistic combination was 35.47% at the end of 24 h. The membrane damage caused by the synergistic combination was spectrophotometrically measured (A = 0.21) and further confirmed by SEM analysis. According to the MTT assay, both carvacrol and meropenem did not show any statistically significant cytotoxic effect on Vero cells (p > 0.05). In conclusion, the results suggest that carvacrol and meropenem can act synergistically to inhibit the growth of CRKP.
650    _2
$a zvířata $7 D000818
650    _2
$a antibakteriální látky $x farmakologie $7 D000900
650    _2
$a karbapenemy $x farmakologie $7 D015780
650    _2
$a Cercopithecus aethiops $7 D002522
650    _2
$a cymeny $7 D000081007
650    _2
$a synergismus léků $7 D004357
650    12
$a Klebsiella pneumoniae $7 D007711
650    _2
$a meropenem $x farmakologie $7 D000077731
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a Vero buňky $7 D014709
650    12
$a beta-laktamasy $x genetika $7 D001618
655    _2
$a časopisecké články $7 D016428
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 67, č. 1 (2022), s. 143-156
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34729712 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220207 $b ABA008
991    __
$a 20240416150928 $b ABA008
999    __
$a ok $b bmc $g 1757408 $s 1157147
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 67 $c 1 $d 143-156 $e 20211102 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
LZP    __
$a Pubmed-20220207

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...